Report cover image

2025 Global Animal Health Market Analysis, Competitive Landscape and Global Forecasts: Accelerated Rate of Change and Regulatory Uncertainty - Performance, Capabilities, Goals and Strategies of Leading Suppliers

Published Sep 25, 2025
Length 106 Pages
SKU # VPG20413584

Description

Will the industry consolidate, decentralize, or undergo a bimodal transformation?
How will the current trends affect the major market segments?
Which companies will enter the market and which will not survive?

This new report analyzes strategies, marketing tactics and technological know-how of the world’s leading animal health companies, including:

  • Five-year forecasts for:
    Major market segments
    Key geographic regions

  • Assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics and other technologies.

    Company Profiles

    Bayer
    Rising demand for collars
    Focusing on parasiticides and anti-infectives
    Strong position in parasiticides
    Animal health R&D
    Worldwide marketing network
    Emerging markets
    Re-registering existing products
    Present structure
    Diverse businesses
    Challenged by animal disease outbreaks
    Europe's premier research organization
    Animal health R&D
    Crop science segment
    Monsanto acquisition
    Supervisory board

    Boehringer Ingelheim
    Sales and growth
    Animal health is one of the major pillars
    Swine vaccine Ingelvac circoflex
    Merial animal health
    U.S. animal health market position
    Promoting Eqvalan line
    Seeking to reinforce position in livestock market
    Strategies supported by collaborations
    Merial R&D programs
    Collaborative efforts
    Porcine Reproductive and Respiratory Syndrome (PRRS)
    Decentralized R&D

    Ceva
    Sales, growth and R&D investment
    Biomune, Phylaxia and French sites
    Hatcher automation and in-ovo vaccination
    India acquisition
    Brazil--important strategic market
    Merial swine vaccines acquisition

    Elanco
    Strong technological base
    Fermentation and chemical synthesis
    Strong base in antibiotics and anticoccidials
    Expiration of patents caused restructuring
    US marketing
    Lilly Japan
    Focused marketing strategies
    Well-established relationship with customers
    Multi-disciplinary business with diverse product portfolio
    In the midst of strategic decisions
    Stepping up efforts to curtail time to market
    Could divest animal health
    Changed product mix
    Strategic collaborations
    Broadening portfolio of companion animal medicines
    Hard look at bottom line

    Merck
    Sales and growth
    Extensive know-how in animal health
    Sphereon technology
    Expanding worldwide poultry business
    Poultry biological research laboratories
    Segmented poultry-product line
    Mitigated generic competition
    R&D productivity improving
    Patents, economies of scale, and powerful intellectual base

    Phibro
    Sales and growth
    Extensive portfolio of antibiotics and antibacterials
    Sales force, sales offices and distribution network
    Animal health R&D facilities

    Virbac
    Sales and growth
    Eli Lilly dog parasiticides acquisition
    Product portfolio
    Formulation know-how
    Waltham nutrition products
    Reorganized European distribution
    Decentralized approach for food-producing animals
    Benefitting from new companion animal products
    Focusing on niche markets
    Seeking expansion in the U.S.

    Zoetis
    Majority of revenue from production animals
    Largest market share in the industry
    Poultry and swine revenue declining
    Scale allows to use own sales force in emerging markets
    Management continues cost-cutting efforts
    Reassessing manufacturing infrastructure
    Market-leading position in emerging markets
    Leading share in Asia-Pacific, Canada and Latin America
    Fragmented customer base
    Leading position in fastest-growing markets
    Contains 110 pages and 6 tables

    Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.
  • Table of Contents

    106 Pages
    TOC available on request
    How Do Licenses Work?
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.